379 related articles for article (PubMed ID: 19250513)
21. [Helicobacter pylori infection and phagocytosis].
Demiray E; Bekmen N
Mikrobiyol Bul; 2008 Jan; 42(1):177-84. PubMed ID: 18444577
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori: phenotypes, genotypes and virulence genes.
Proença-Modena JL; Acrani GO; Brocchi M
Future Microbiol; 2009 Mar; 4(2):223-40. PubMed ID: 19257848
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of virulent Helicobacter pylori strains in symptomatic Bulgarian patients.
Boyanova L; Markovska R; Yordanov D; Marina M; Ivanova K; Panayotov S; Gergova G; Mitov I
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):374-80. PubMed ID: 19631090
[TBL] [Abstract][Full Text] [Related]
24. Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.
Chomvarin C; Ottiwet O; Hahnvajanawong C; Intapan PM; Wongwajana S
Int J Infect Dis; 2009 Sep; 13(5):647-54. PubMed ID: 19233700
[TBL] [Abstract][Full Text] [Related]
25. Virulence factors of Helicobacter pylori.
Newell DG
Scand J Gastroenterol Suppl; 1991; 187():31-8. PubMed ID: 1775922
[TBL] [Abstract][Full Text] [Related]
26. B cells pulsed with Helicobacter pylori antigen efficiently activate memory CD8+ T cells from H. pylori-infected individuals.
Azem J; Svennerholm AM; Lundin BS
Clin Immunol; 2006; 118(2-3):284-91. PubMed ID: 16324887
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of virulence factors of Helicobacter pylori].
Kamiya S
Rinsho Byori; 2001 Feb; 49(2):116-20. PubMed ID: 11307301
[TBL] [Abstract][Full Text] [Related]
28. [Helicobacter pylori--bacterial characteristics].
Kalenić S; Plecko V; Presecki V; Katicić M; Dominis M
Lijec Vjesn; 2002 Sep; 124 Suppl 1():10-3. PubMed ID: 12592808
[TBL] [Abstract][Full Text] [Related]
29. Pathogenic properties of Helicobacter pylori.
Moran AP
Scand J Gastroenterol Suppl; 1996; 215():22-31. PubMed ID: 8722379
[TBL] [Abstract][Full Text] [Related]
30. Effects of cholesterol on Helicobacter pylori growth and virulence properties in vitro.
Jiménez-Soto LF; Rohrer S; Jain U; Ertl C; Sewald X; Haas R
Helicobacter; 2012 Apr; 17(2):133-9. PubMed ID: 22404444
[TBL] [Abstract][Full Text] [Related]
31. Role of type IV secretion in Helicobacter pylori pathogenesis.
Backert S; Selbach M
Cell Microbiol; 2008 Aug; 10(8):1573-81. PubMed ID: 18410539
[TBL] [Abstract][Full Text] [Related]
32. Pathogenic mechanisms of Helicobacter pylori.
Dunn BE
Gastroenterol Clin North Am; 1993 Mar; 22(1):43-57. PubMed ID: 8449569
[TBL] [Abstract][Full Text] [Related]
33. [Characterization of the Helicobacter pylori vacuolating cytotoxin gene in gastric biopsy specimens from patients living in Tolima, Colombia].
López AM; Delgado MP; Jaramillo C; Amézquita A; Parra G; Echeverry MM
Rev Argent Microbiol; 2009; 41(1):4-10. PubMed ID: 19391518
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 induction by Helicobacter pylori in human macrophages is dependent on phagocytosis.
Odenbreit S; Linder S; Gebert-Vogl B; Rieder G; Moran AP; Haas R
Helicobacter; 2006 Jun; 11(3):196-207. PubMed ID: 16684268
[TBL] [Abstract][Full Text] [Related]
35. Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors.
Molnar B; Galamb O; Sipos F; Leiszter K; Tulassay Z
Dig Dis; 2010; 28(4-5):604-8. PubMed ID: 21088410
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells.
Machado AM; Figueiredo C; Touati E; Máximo V; Sousa S; Michel V; Carneiro F; Nielsen FC; Seruca R; Rasmussen LJ
Clin Cancer Res; 2009 May; 15(9):2995-3002. PubMed ID: 19383819
[TBL] [Abstract][Full Text] [Related]
37. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis.
Betten A ; Bylund J; Christophe T; Boulay F; Romero A; Hellstrand K; Dahlgren C
J Clin Invest; 2001 Oct; 108(8):1221-8. PubMed ID: 11602630
[TBL] [Abstract][Full Text] [Related]
38. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.
D'Elios MM; Amedei A; Cappon A; Del Prete G; de Bernard M
FEMS Immunol Med Microbiol; 2007 Jul; 50(2):157-64. PubMed ID: 17521355
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter pylori infection and family history of gastric cancer decrease expression of FHIT tumor suppressor gene in gastric mucosa of dyspeptic patients.
Stec-Michalska K; Peczek L; Michalski B; Wisniewska-Jarosinska M; Krakowiak A; Nawrot B
Helicobacter; 2009 Oct; 14(5):126-34. PubMed ID: 19751438
[TBL] [Abstract][Full Text] [Related]
40. VacA and HP-NAP, Ying and Yang of Helicobacter pylori-associated gastric inflammation.
D'Elios MM; Montecucco C; de Bernard M
Clin Chim Acta; 2007 May; 381(1):32-8. PubMed ID: 17368441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
